We will continue to study the molecular epidemiology of influenze viruses using biochemical techniques. A study will be undertaken to contrast the evolutionary changes in the earlier H1N1 strains (1950-57) with those observed in the 1950-like H1N1 strains which were reintroduced into the population in 1977. Genetic variation will also be studied with respect to equine 1 influenza viruses (H7N7). These viruses appear to undergo slower antigenic change than human influenza viruses. In addition, we will analyze the genetic composition and antigenic properties of new antigenic """"""""drift"""""""" and antigenic """"""""shift"""""""" variants of influenza viruses isolated in the future. We have developed a convenient assay to measure amber suppressor tRNA activity in higher eukaryotic cells. This assay is based on the quantitation of the NS1 polypeptide and its Su+ tRNA mediated readthrough product after virus infection. It is planned to extend this method for the measurement of opal and ochre suppressor tRNAs and to search for natural nonsense suppressor tRNA activities in higher eukaryotic cells. With the availability of genetically engineered cells containing Su+ tRNAs it should also be possible to isolate nonsense mutants of influenza virus and to use them for studying the structure/function relationship of influenza viral genes. We also plan to apply the suppressor systems to generate mutant proteins of cloned influenza virus genes which are expressed via SV40 vectors. This approach will allow us to systematically change specific amino acids in a single viral protein in an effort to identify those amino acids which are crucial for the function of the protein.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI011823-13
Application #
3125031
Study Section
Experimental Virology Study Section (EVR)
Project Start
1977-05-01
Project End
1989-04-30
Budget Start
1986-05-01
Budget End
1987-04-30
Support Year
13
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Durbin, J E; Fernandez-Sesma, A; Lee, C K et al. (2000) Type I IFN modulates innate and specific antiviral immunity. J Immunol 164:4220-8
O'Neill, R E; Talon, J; Palese, P (1998) The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J 17:288-96
Rodrigues, M; Li, S; Murata, K et al. (1994) Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol 153:4636-48
Li, S; Rodrigues, M; Rodriguez, D et al. (1993) Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A 90:5214-8
Luo, G; Palese, P (1992) Genetic analysis of influenza virus. Curr Opin Genet Dev 2:77-81
Luo, G; Bergmann, M; Garcia-Sastre, A et al. (1992) Mechanism of attenuation of a chimeric influenza A/B transfectant virus. J Virol 66:4679-85
Bergmann, M; Garcia-Sastre, A; Palese, P (1992) Transfection-mediated recombination of influenza A virus. J Virol 66:7576-80
Lin, D A; Roychoudhury, S; Palese, P et al. (1991) Evolutionary relatedness of the predicted gene product of RNA segment 2 of the tick-borne Dhori virus and the PB1 polymerase gene of influenza viruses. Virology 182:1-7
Enami, M; Sharma, G; Benham, C et al. (1991) An influenza virus containing nine different RNA segments. Virology 185:291-8
Luo, G X; Luytjes, W; Enami, M et al. (1991) The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J Virol 65:2861-7

Showing the most recent 10 out of 38 publications